Author:
Luo Yingqi,Wu Wenhao,Zha Dailong,Zhou Wenmin,Wang Chengxu,Huang Jianan,Chen Shaobin,Yu Lihong,Li Yuanzhi,Huang Qinghui,Zhang Jianye,Zhang Chao
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference29 articles.
1. Rebecca L. Siegel, Kimberly D. Miller, Ahmedin. Jemal. Cancer statistics, 2020. CA Cancer J. Clin, 2020, 70(1): 7-30. doi: 10.3322/caac.21590.
2. Small-molecule inhibitors of breast cancer-related targets: Potential therapeutic agents for breast cancer;Liu;Eur J Med Chem,2021
3. C. A Parise, V. Caggiano, Breast cancer survival defined by the ER/PR/HER2 subtypes and a surrogate classification according to tumor grade and immunohistochemical biomarkers. J. Cancer. Epidemiol. 2014, 2014: 469251 10.1155/2014/469251.
4. Triple negative breast cancer: a thorough review of biomarkers;Lopes da Silva;Critical Crit Rev Oncol Hematol,2020
5. Panoptic overview of triple-negative breast cancer in Nigeria: current challenges and promising global initiatives;Wright;J Glob Oncol,2018
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献